NDC 68788-9325

Gabapentin

Gabapentin

Gabapentin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is Gabapentin.

Product ID68788-9325_27f1f801-f096-4c09-8eae-34833dd2e44a
NDC68788-9325
Product TypeHuman Prescription Drug
Proprietary NameGabapentin
Generic NameGabapentin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2015-04-13
Marketing CategoryANDA / ANDA
Application NumberANDA078428
Labeler NamePreferred Pharmaceuticals, Inc.
Substance NameGABAPENTIN
Active Ingredient Strength100 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68788-9325-9

90 CAPSULE in 1 BOTTLE (68788-9325-9)
Marketing Start Date2015-04-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-9325-3 [68788932503]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-04-13
Marketing End Date2019-09-26

NDC 68788-9325-8 [68788932508]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-04-13
Marketing End Date2019-09-26

NDC 68788-9325-9 [68788932509]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-04-13
Marketing End Date2019-09-26

NDC 68788-9325-1 [68788932501]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-04-13
Marketing End Date2019-09-26

NDC 68788-9325-6 [68788932506]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-04-13
Marketing End Date2019-09-26

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN100 mg/1

OpenFDA Data

SPL SET ID:66944a90-fc9b-497d-8340-f25d5ef50139
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310430

    • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Gabapentin" or generic name "Gabapentin"

    NDCBrand NameGeneric Name
    0093-4443GabapentinGabapentin
    0093-4444GabapentinGabapentin
    0143-3991GabapentinGabapentin
    0143-3993GabapentinGabapentin
    0143-3994GabapentinGabapentin
    0143-9992GabapentinGabapentin
    0143-9993GabapentinGabapentin
    0143-9994GabapentinGabapentin
    67877-222GabapentinGabapentin
    67877-223GabapentinGabapentin
    67877-224GabapentinGabapentin
    67877-428GabapentinGabapentin
    67877-429GabapentinGabapentin
    68001-006GabapentinGabapentin
    68001-007GabapentinGabapentin
    68071-1212GABAPENTINGABAPENTIN
    68071-1292GabapentinGabapentin
    68071-1808GABAPENTINGABAPENTIN
    68071-1907GABAPENTINGABAPENTIN
    68071-1995GabapentinGabapentin
    68071-3230GABAPENTINGABAPENTIN
    68071-3046GabapentinGabapentin
    68071-3244GabapentinGabapentin
    68071-4087GabapentinGabapentin
    68071-3086GABAPENTINGABAPENTIN
    68071-3383GABAPENTINGABAPENTIN
    68071-3314GABAPENTINGABAPENTIN
    68071-4049GABAPENTINGABAPENTIN
    68071-4241GABAPENTINGABAPENTIN
    68071-4099GabapentinGabapentin
    68071-4113GabapentinGabapentin
    68071-4292GabapentinGabapentin
    68071-4180GabapentinGabapentin
    68071-4090GabapentinGabapentin
    68071-4329GabapentinGabapentin
    68071-4603GabapentinGabapentin
    68071-4169GabapentinGabapentin
    68071-4346GabapentinGabapentin
    68071-4366GabapentinGabapentin
    68071-4729GabapentinGabapentin
    68071-4402GABAPENTINGABAPENTIN
    68071-4784GABAPENTINGABAPENTIN
    68084-774GabapentinGabapentin
    68084-783GabapentinGabapentin
    68084-797GabapentinGabapentin
    68084-762GabapentinGabapentin
    0440-5562GABAPENTINGABAPENTIN
    0440-5563GABAPENTINGABAPENTIN
    68084-802GabapentinGabapentin
    68151-1028GabapentinGabapentin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.